Industry Report

Biological and biosimilar medicines market in Poland 2019

Market analysis and development forecasts for 2019-2024

This product is also available in Polish

Biological and biosimilar medicines market in Poland 2019

Market analysis and development forecasts for 2019-2024

View Leaflet
Other versions: Polish
Sector: Biologic / Biosimilar drugs
Country: Poland

This report provides a comprehensive overview of the market for biologic medicines and biosimilars in Poland, including its value, growth rate, structure, and key trends and developments. It is an invaluable tool for market players, helping them plan better and react faster to a changing landscape.

Content

It also presents the findings of an exclusive survey of market participants – drug manufacturers, distributors, suppliers of active ingredients, and R&D firms and institutions – in which we gauged their opinions on the current situation in the segment, its key growth drivers and challenges, the outlook for 2019-2024, and more.


What is the content of the report?

 

The report contains the following data and information:

  • value and growth rate of the market for biologic medicines in Poland, with a breakdown into reference biologics and biosimilars, and into outpatient medicines (pharmacy sales) and hospital medicines (therapeutic programmes & chemotherapy)
  • growth prospects – for the total market and for main product categories (with a breakdown into reference biologics and biosimilars)
  • market structure
  • profiles of leading players (with a breakdown into reference biologics and biosimilars)
  • best-selling products (with a breakdown into reference biologics and biosimilars)
  • main categories of biologic medicines
  • latest trends and developments and their impact on the biologics market
  • anticipated trends and developments and their impact on the biologics market
  • key market growth factors and inhibitors
  • epidemiological trends

And additionally:

  • exclusive PMR analyses and estimates of the value of the market for reference biologics and biosimilars in Poland in 2017-2019, together with our own classification of medicines
  • findings from two new PMR studies: a poll of market players, and a survey of physicians
  • key changes in the reimbursement list pertaining to biologic medicines
  • expiry of patents for important biologic medicines
Benefits

Why to buy the report?

The report is an invaluable resource that will help you:

  • stay abreast of developments in the market for reference biologics and biosimilars in Poland
  • identify areas with the greatest growth potential and those already saturated
  • keep track of what competitors are doing and planning
  • estimate current and future demand for particular categories of medicines
  • prepare to enter the biologics market in Poland
  • develop growth strategies and plan investment projects
  • analyse investment and credit risk in this market
  • react swiftly to defend or grow market share
Users

Who benefits from the analysis?

Executive board members and persons in charge of marketing, sales, strategy, R&D, and biologics at the following:

  • pharma firms that have reference biologics or biosimilars in their portfolios
  • pharma firms looking to expand into biologics  or already working on them
  • pharmaceutical distributors
  • clinical trials firms
  • suppliers of technologies and active ingredients for biologic medicines
  • marketing agencies working for pharma and healthcare clients
  • logistics operators specialised in pharmaceuticals
  • financial institutions  interested in the pharma and healthcare markets in Poland: banks, stock brokerages, investment funds
  • Methodology
  • Executive summary

Learn more about this report

To find out more about Biological and biosimilar medicines market in Poland 2019 report please log in

If you are not a current PMR client, contact us at +48 12 340 51 30.

Client log in Send @mail
Other versions: Polish
Sector: Biologic / Biosimilar drugs
Country: Poland

Each licence option entitles Client to make use of the product within the following limits/ number of users:

Standard – up to 2 users

Standard Plus – between 3 and 9 users

Corporate – from 10 unique users and more

For more information please visit: mypmr.pro/terms-and-conditions

This content is available for current PMR clients. If you are a client please log-in or contact us for more information at: +48 12 340 51 30.

Jest to zawartość dostępna dla obecnych klientów PMR. Jeśli jesteś klientem, zaloguj się lub skontaktuj się z nami, aby uzyskać więcej informacji: +48 12 340 51 30.